Pharmaceutical preparation for the treatment of diabetes and process for its manufacture

There is described the use of physiologically acceptable enzyme mixtures having lipolytic, proteolytic and amylolytic activity, of microbial or animal origin, preferably digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the manufacture of a pharmace...

Ausführliche Beschreibung